Oral lesions in lupus erythematosus-cytokines profiles of inflammatory infiltrate

Journal of Cutaneous Pathology

Volumn 37, Issue 4, 2010, Pages 439-445

  Marques, Elisa R M C ^a   Lourenço, Silvia Vanessa ^a   Lima, Dirce M ^a   Nico, Marcello Menta S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; MOUTH; SKIN LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; CYTOKINES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; MIDDLE AGED; MOUTH;

EID: 77149160032     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2009.01424.x     Document Type: Article

References (40)

1. Crowson AN, Magro C. The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol 2001 28 : 1.
2. Kuhn A, Ruzicka, T. Classification of cutaneous lupus erythematosus. In Kuhn A, Lehmann P, Ruzicka T, eds. Cutaneous lupus erythematosus. Germany : Springer, 2005 5.
3. Karjalainen TK, Tomich CE. A histopathologic study of oral mucosal lupus erythematosus. Oral Surg Oral Med Oral Pathol 1989 67 : 547.
4. Nico MMS, Vilela MAC, Rivitti EA, Lourenço SV. Oral lesions in lupus erythematosus: correlation with cutaneous lesions. Eur J Dermatol 2008 18 : 376.
5. Burge SM, Frith PA, Juniper RP, Wojnarowska F. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol 1989 121 : 727.
6. Jonsson R, Heyden G, Westberg NG, Nyberg G. Oral mucosal lesions in systemic lupus erythematosus: a clinical, histopathological and immunopathological study. J Rheumatol 1984 11 : 38.
7. Schiodt M. Oral discoid lupus erythematosus. III. A histo-pathologic study of sixty-six patients. Oral Surg Oral Med Oral Pathol 1984 57 : 281.
8. Lourenço SV, Sotto MN, Vilela MAC, Carvalho FRG, Rivitti EA, Nico MMS. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of epithelial maturation. J Cutan Pathol 2006 33 : 657.
9. Lourenço SV, Carvalho FRG, Boggio P, et al. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. J Cutan Pathol 2007 34 : 558.
10. Toro JR, Finlay D, Dou X, Zheng SC, LeBoit PE, Connolly MK. Detection of type I cytokines in discoid lupus erythematosus. Arch Dermatol 2000 136 : 1497.
11. Stein LF, Saed GM, Fivenson DP. T-cell cytokine network in cutaneous lupus erythematosus. J Am Acad Dermatol 1997 36 : 191.
12. Kuhn A, Bijl M. Pathogenesis of cutaneous lupus erythematosus. Lupus 2008 17 : 389.
13. Lin JH, Dutz JP, Sontheimer RD, Werth VP. Pathophysiology of cutaneous Lupus Erythematosus. Clinic Rev Allerg Immunol 2007 33 : 85.
14. Werth VP. Cutaneous lupus insigts into pathogenesis and disease classification. Bull NYU Hosp Jt Dis 2007 65 : 200.
15. Wenzel J, WörenKämper E, Freutel S, et al. Enhanced type I interferon signalling promotes ThI-biased inflammation in cutaneous lupus erythematosus. J Pathol 2005 205 : 435.
16. Werth VP, Zhang W, Dortzbach K, Sullivan K. Association of a promoter polymorphism of Tumor Necrosis Factor-α with Subacute Cutaneous Lupus Erythematosus and distinct photoregulation of transcription. J Invest Dermatol 2000 115 : 726.
17. Rahman A. Cytokines in systemic lupus erythematosus. Arthritis Res Ther 2003 5 : 160.
18. Singh AK. Cytokines play a central role in the pathogenesis of systemic lupus erythematosus. Med Hypotheses 1992 39 : 356.
19. Singh AK. Do cytokines play a role in systemic lupus erythematosus? J Roy Coll Phys Lond 1992 26 : 374.
20. Aringer M, Smolen JS. SLE-Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus. Arthritis Res Ther 2003 5 : 172.
21. Uppal S, Hayat S, Raghupathy R. Efficacy and safety of infliximab in active SLE: a pilot study. Lupus 2009 18 : 690.
22. Williams EL, Gadola S, Edwards CJ. Anti-TNF-induced lupus. Rheumatology (Oxford). 2009 48 : 716.
23. Suárez A, López P, Mozo L, Gutiérrez C. Differential effect of IL-10 and TNF-α genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 2005 64 : 1605.
24. Richaud-Patin Y, Alcocer-Varela J, Llorente L. High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev Invest Clin 1995 47 : 267.
25. Hass C, Ryffel B, Le Hir M. IFN- γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB × NZW) F1 mice. J Immunol 1998 160 : 3713.
26. Barcellini W, Rizzard GP, Borghi MO, Nicoletti F, Fain C, Del Papa N. In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity. Lupus 1996 5 : 139.
27. Linker-Israeli M. Cytokine abnormalities in human lupus. Clin Immunol Immunopathol 1992 63 : 10.
28. Dean GS, Tyrrell-Price J, Crawley E, Isenberg DA. Cytokines and systemic lupus erythematosus. Ann Rheum Dis 2000 59 : 243.
29. Csiszár A, Nagy GY, Gergely P, Pozsonyi T, Pócsik É. Increased interferon-gamma (IFN-γ), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 2000 122 : 464.
30. Weiss E, Mamelak AJ, Morgia SL, et al. The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases. J Am Acad Dermatol 2004 50 : 657.
31. Kalsi JK, Grossman J, Kim J, et al. Peptides from antibodies to DNA elicit cytokine release from peripheral blood momonuclear cells of patients with systemic lupus erythematosus: relation of cytokine pattern to disease duration. Lupus 2004 13 : 490.
32. Horwits DA, Wang H, Gray JD. Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but not in interleukin-4 mRNA. Lupus 1994 3 : 423.
33. Parronchi P, De Carli M, Manetti R, et al. IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 1992 149 : 2977.
34. Bijl M, Kallenberg CGM. Ultraviolet light and cutaneous lupus. Lupus 2006 15 : 724.
35. Casciola-Rosen L, Rosen A. Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus 1997 6 : 175.
36. Rosenbaum M, Werth VP. Pathogenesis of cutaneous lupus erythematosus: the role of ultraviolet light. In Kuhn A, Lehmann P, Ruzicka T, eds. Cutaneous lupus erythematosus. Germany : Springer, 2005 251.
37. Werth VP, Bashir MM, Zhang W. IL-12 completely blocks ultraviolet-induced secretion of tumor necrosis factor alpha from cultured skin fibroblasts and keratinocytes. J Invest Dermatol 2003 120 : 116.
38. Kuhn A, Sonntag M, Richter-Hintz D, et al. Phototesting in lupus erythematosus: a 15 year experience. J Am Acad Dermatol 2001 45 : 86.
39. Lehmann P, Holzle E, Kind P, Goerz G, Plewig G. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 1990 22 : 181.
40. Lee SS, Ackerman AB. Lupus dermatitis is an expression of systemic lupus erythematosus. Dermatopathol Pract Concept 1997 3 : 346.